Product
Camosunate Junior Tablets 7-13 Years (Artesunate 100 mg + Amodiaquine 300 mg) x 6 tablets
Antimalarials
Product details
ACT antimalarial (junior tablets)
Camosunate Junior is an artemisinin-based combination therapy (ACT) containing artesunate and amodiaquine, used for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum in children aged 7–13 years.
Active ingredients
Each tablet contains: Artesunate 100 mg + Amodiaquine 300 mg.
Pack size
1 × 6 tablets (blister pack).
How to use
Use only as directed by a healthcare professional. Follow the leaflet for dosing guidance.
Storage
Store in a cool, dry place away from heat and moisture.
Buying for a business?
Prepared for repeat business ordering: Camosunate Junior Tablets 7-13 Years (Artesunate 100 mg + Amodiaquine 300 mg) x 6 tablets.
Wholesale phone: +234 704 489 6881
Need help before you buy?
Speak to the pharmacy team
Use the product enquiry button, contact page, or WhatsApp if you need availability, dosage, or delivery guidance.
Keep browsing
